Literature DB >> 15336985

Calcium signaling and polycystin-2.

Georgia I Anyatonwu1, Barbara E Ehrlich.   

Abstract

Polycystic kidney disease (PKD) is caused by mutations in two genes, PKD1 and PKD2, which encode for the proteins, polycystin-1 (PC1) and polycystin-2 (PC2), respectively. Although disease-associated mutations have been identified in these two proteins, the sequence of molecular events leading up to clinical symptoms is still unknown. PC1 resides in the plasma membrane and it is thought to function in cell-cell and cell-matrix interactions, whereas PC2 is a calcium (Ca2+) permeable cation channel concentrated in the endoplasmic reticulum. Both proteins localize to the primary cilia where they function as a mechanosensitive receptor complex allowing the entry of Ca2+ into the cell. The downstream signaling pathway involves activation of intracellular Ca2+ release channels, especially the ryanodine receptor (RyR), but subsequent steps are still to be identified. Elucidation of the signaling pathway involved in normal PC1/PC2 function, the functional consequences of PC1/PC2 mutation, and the role of Ca2+ signaling will all help to unravel the molecular mechanisms of cystogenesis in PKD. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336985     DOI: 10.1016/j.bbrc.2004.08.043

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference.

Authors:  Meral Gunay-Aygun; Ellis D Avner; Robert L Bacallao; Peter L Choyke; Joseph T Flynn; Gregory G Germino; Lisa Guay-Woodford; Peter Harris; Theo Heller; Julie Ingelfinger; Frederick Kaskel; Robert Kleta; Nicholas F LaRusso; Parvathi Mohan; Gregory J Pazour; Benjamin L Shneider; Vicente E Torres; Patricia Wilson; Colleen Zak; Jing Zhou; William A Gahl
Journal:  J Pediatr       Date:  2006-08       Impact factor: 4.406

Review 2.  Function and regulation of TRPP2 at the plasma membrane.

Authors:  Leonidas Tsiokas
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-25

Review 3.  Physiology of cholangiocytes.

Authors:  James H Tabibian; Anatoliy I Masyuk; Tetyana V Masyuk; Steven P O'Hara; Nicholas F LaRusso
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

4.  Activation of a latent nuclear localization signal in the NH2 terminus of γ-ENaC initiates feedback regulation of channel activity.

Authors:  Elena Mironova; James D Stockand
Journal:  Am J Physiol Renal Physiol       Date:  2010-02-10

Review 5.  Intercellular Ca(2+) waves: mechanisms and function.

Authors:  Luc Leybaert; Michael J Sanderson
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

6.  Calcium-induced conformational changes in C-terminal tail of polycystin-2 are necessary for channel gating.

Authors:  Andjelka S Ćelić; Edward T Petri; Jennifer Benbow; Michael E Hodsdon; Barbara E Ehrlich; Titus J Boggon
Journal:  J Biol Chem       Date:  2012-04-03       Impact factor: 5.157

Review 7.  Decoding calcium signaling across the nucleus.

Authors:  André G Oliveira; Erika S Guimarães; Lídia M Andrade; Gustavo B Menezes; M Fatima Leite
Journal:  Physiology (Bethesda)       Date:  2014-09

8.  Flow regulation of collecting duct endothelin-1 production.

Authors:  Brianna Lyon-Roberts; Kevin A Strait; Evan van Peursem; Wararat Kittikulsuth; Jennifer S Pollock; David M Pollock; Donald E Kohan
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-22

9.  ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice.

Authors:  Carlo Spirli; Stefano Okolicsanyi; Romina Fiorotto; Luca Fabris; Massimiliano Cadamuro; Silvia Lecchi; Xin Tian; Stefan Somlo; Mario Strazzabosco
Journal:  Gastroenterology       Date:  2009-09-18       Impact factor: 22.682

10.  Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy.

Authors:  Jere Paavola; Simon Schliffke; Sandro Rossetti; Ivana Y-T Kuo; Shiaulou Yuan; Zhaoxia Sun; Peter C Harris; Vicente E Torres; Barbara E Ehrlich
Journal:  J Mol Cell Cardiol       Date:  2013-01-30       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.